American Portfolios Advisors’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $1.68K | Hold |
1,031
| – | – | ﹤0.01% | 3171 |
|
|
2022
Q2 | $1.35K | Hold |
1,031
| – | – | ﹤0.01% | 3218 |
|
|
2022
Q1 | $1.66K | Hold |
1,031
| – | – | ﹤0.01% | 3268 |
|
|
2021
Q4 | $2.13K | Hold |
1,031
| – | – | ﹤0.01% | 3153 |
|
|
2021
Q3 | $4K | Hold |
1,031
| – | – | ﹤0.01% | 2942 |
|
|
2021
Q2 | $3.3K | Hold |
1,031
| – | – | ﹤0.01% | 2987 |
|
|
2021
Q1 | $2.24K | Hold |
1,031
| – | – | ﹤0.01% | 2963 |
|
|
2020
Q4 | $2.31K | Hold |
1,031
| – | – | ﹤0.01% | 2662 |
|
|
2020
Q3 | $2.75K | Hold |
1,031
| – | – | ﹤0.01% | 2490 |
|
|
2020
Q2 | $3.16K | Hold |
1,031
| – | – | ﹤0.01% | 2393 |
|
|
2020
Q1 | $2.02K | Hold |
1,031
| – | – | ﹤0.01% | 2397 |
|
|
2019
Q4 | $2.95K | Hold |
1,031
| – | – | ﹤0.01% | 2461 |
|
|
2019
Q3 | $3.78K | Buy |
1,031
+500
| +94% | +$1.84K | ﹤0.01% | 2288 |
|
|
2019
Q2 | $2.2K | Buy |
+531
| New | +$2.2K | ﹤0.01% | 2451 |
|